A7.20 Response to Infliximab Therapy can be Predicted using Distinct, Non-Overlapping Gene Panels of Peripheral Blood Gene Expression in Rheumatoid Arthritis and Crohn’s Disease

Background Biological therapies targeting tumour necrosis factor α (TNF-α) have been widely used to treat chronic inflammatory disorders including rheumatoid arthritis (RA) and Crohn’s disease (CD). As these treatment modalities are rather expensive, there is a need for biomarkers that may predict t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the rheumatic diseases 2013-03, Vol.72 (Suppl 1), p.A55-A55
Hauptverfasser:	Szekanecz, Zoltán, Meskó, Bertalan, Poliska, Szilárd, Váncsa, Andrea, Palatka, Károly, Holló, Zsolt, Zahuczky, Gábor, Podani, János, Horváth, Attila, Steiner, László, Nagy, László
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!